ACM
ABVX

ACT Capital Management’s Abivax ABVX Stock Holding History

ACT Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
97,000
+26,100
+37% +$2.95M 8.45% 3
2026
Q1 		$7.89M Buy
70,900
+7,000
+11% +$828K 6.2% 6
2025
Q4 		$8.62M Buy
+63,900
New +$6.97M 6.97% 4

Other funds holding ABVX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
SCS
Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return

ACT Capital Management's ABVX Position: Q2 2026 in Review

ACT Capital Management increased its Abivax (ABVX) stake by 37% in Q2 2026, buying an estimated $2.95M and bringing the position to 97,000 shares worth $12.9M. The position accounts for 8.45% of the portfolio, ranked #3.

ACT Capital Management first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • ACT Capital Management held 97,000 shares of Abivax worth $12.9M as of Q2 2026.
  • ACT Capital Management bought 26,100 Abivax shares in Q2 2026, an estimated $2.95M.
  • Abivax made up 8.45% of ACT Capital Management's portfolio in Q2 2026, its #3 holding.
  • ACT Capital Management first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.